✦ LIBER ✦
6096 POSTER FOLFOXIRI (Irinotecan, Oxaliplatin, and Infusional 5FU/LV) in Combination With Panitumumab (P) in the First-line Treatment of Metastatic Colorectal Cancer (mCRC) Patients (pts) Selected for KRAS, BRAF, NRas and HRas Mutational Status – a Phase II Study by the G.O.N.O. Group
✍ Scribed by Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; Bergamo, F.; Cappetta, A.; Zagonel, V.; Falcone, A.
- Book ID
- 123320473
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 49 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.